Abstract
A series of new cyclodextrin linked coumarins was synthesized (12a-g) and evaluated for th ei r antimicrobial activity. All the compounds investigated have shown significant antimicrobial a c t iv i ty against gram-positive and gramnegative bacterial strains as well as a few fungal strains. The compounds exhibited upto 4-fold improved biological activity than their precursors. The results suggest that the improvement in bioavailability is responsible for the enhanced biological activity.
Keywords: Amino-thaizolyl coumarin, Cyclodextrin, Antibacterial, Bioavailability, Coumarins, Antimicrobial agents, Gram-positive, Grame-negative, Cyclodextrin,, Therapeutically active drug, Systemic circulation, Anti-mycobacterium, Hepatitis C RNA synthetase, Coumarin derivatives, Anti-tumour, Anticancer activities, Oligosaccharides, Indomethacin, Prednisolone, Antimicrobial activity, Coumarin-thiazole derivatives, Clotrimazole, Antifungal activity, Standard drug, Lipophilicity, Aqueous Solubility (log S), Antifungal assay, Potato Dextrose Agar, Inhibition zones, Anti-tubercular agents, Poten inhibitors, Leukocyte activation
Letters in Drug Design & Discovery
Title: Synthesis of Cyclodextrin Derivatives of Amino-(thiazolyl) Coumarins as Potential Antimicrobial Agents
Volume: 7 Issue: 9
Author(s): Ahmed Kamal, S. F. Adil, Jaki R. Tamboli, B. Siddardha and U. S.N. Murthy
Affiliation:
Keywords: Amino-thaizolyl coumarin, Cyclodextrin, Antibacterial, Bioavailability, Coumarins, Antimicrobial agents, Gram-positive, Grame-negative, Cyclodextrin,, Therapeutically active drug, Systemic circulation, Anti-mycobacterium, Hepatitis C RNA synthetase, Coumarin derivatives, Anti-tumour, Anticancer activities, Oligosaccharides, Indomethacin, Prednisolone, Antimicrobial activity, Coumarin-thiazole derivatives, Clotrimazole, Antifungal activity, Standard drug, Lipophilicity, Aqueous Solubility (log S), Antifungal assay, Potato Dextrose Agar, Inhibition zones, Anti-tubercular agents, Poten inhibitors, Leukocyte activation
Abstract: A series of new cyclodextrin linked coumarins was synthesized (12a-g) and evaluated for th ei r antimicrobial activity. All the compounds investigated have shown significant antimicrobial a c t iv i ty against gram-positive and gramnegative bacterial strains as well as a few fungal strains. The compounds exhibited upto 4-fold improved biological activity than their precursors. The results suggest that the improvement in bioavailability is responsible for the enhanced biological activity.
Export Options
About this article
Cite this article as:
Kamal Ahmed, F. Adil S., R. Tamboli Jaki, Siddardha B. and S.N. Murthy U., Synthesis of Cyclodextrin Derivatives of Amino-(thiazolyl) Coumarins as Potential Antimicrobial Agents, Letters in Drug Design & Discovery 2010; 7 (9) . https://dx.doi.org/10.2174/157018010792929559
DOI https://dx.doi.org/10.2174/157018010792929559 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer
Current Medicinal Chemistry CCL21 and IFNγ Recruit and Activate Tumor Specific T cells in 3D Scaffold Model of Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Difference Gel Electrophoresis: Application in Quantitative Proteomics Research
Current Proteomics Role of Lycopene in the Control of ROS-Mediated Cell Growth: Implications in Cancer Prevention
Current Medicinal Chemistry Triple Negative Breast Cancer: A Tale of Two Decades
Anti-Cancer Agents in Medicinal Chemistry Psychopathological Behaviour and Cognition in Morbid Obesity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Quantifying Risk: The Role of Absolute and Relative Measures in Interpreting Risk of Adverse Reactions from Product Labels of Antipsychotic Medications
Current Drug Safety Collaborative and Defensive Fibroblasts in Tumor Progression and Therapy Resistance
Current Medicinal Chemistry Deleted in Colorectal Cancer (DCC) Pathfinding: Axon Guidance Gene Finally Turned Tumor Suppressor
Current Drug Targets EGFR-Targeting Monoclonal Antibodies in Head and Neck Cancer
Current Cancer Drug Targets Harnessing CD36 to Rein in Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Molecule of the Month
Current Topics in Medicinal Chemistry Circulating Tumor Stem Cells as Biomarkers for Cancer Progression
Recent Patents on Biomarkers The Ubiquitin+Proteasome Protein Degradation Pathway as a Therapeutic Strategy in the Treatment of Solid Tumor Malignancies
Anti-Cancer Agents in Medicinal Chemistry A Co-Module Regulated by Therapeutic Drugs in a Molecular Subnetwork of Alzheimer’s Disease Identified on the Basis of Traditional Chinese Medicine and SAMP8 Mice
Current Alzheimer Research Hedgehog Signaling in the Normal and Neoplastic Mammary Gland
Current Drug Targets Novel Inhibitors of Inosine Monophosphate Dehydrogenase in Patent Literature of the Last Decade
Recent Patents on Anti-Cancer Drug Discovery The Role of TRP Channels in Allergic Inflammation and its Clinical Relevance
Current Medicinal Chemistry Regulation of Polymorphonuclear Leukocyte-Intestinal Epithelial Cell Interactions: Signalling Events and Potential Drug Targets
Current Signal Transduction Therapy Oncogenic Role of SET/I2PP2A for Gynecologic Cancers
Current Drug Targets